Melinta Therapeutics is a biopharmaceutical company founded by Sterling Professors at Yale University
Our mission is to apply Nobel Prize–winning science to develop new therapeutics in the global fight against drug-resistant pathogens.
We are the proud developers of BAXDELA™, an important therapeutic milestone in the treatment of serious skin infections in adult patients.
Melinta Therapeutics, Inc. - The Antibiotics Company
For additional information about BAXDELA, call Melinta Therapeutics at 1-844-MELINTA (1-844-635-4682) or contact the US Food and Drug Administration at 1-888-INFO-FDA (1-888-463-6332).